300199 翰宇药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)18.8586.133-25.968-50.642-25.955
总资产报酬率 ROA (%)3.9201.187-5.526-14.920-9.858
投入资产回报率 ROIC (%)4.6171.415-6.471-17.110-11.247

边际利润分析
销售毛利率 (%)64.89558.36357.09249.30677.336
营业利润率 (%)45.9067.150-27.344-117.646-52.647
息税前利润/营业总收入 (%)54.50918.312-8.212-89.442-37.669
净利润/营业总收入 (%)42.5863.521-30.514-119.486-52.895

收益指标分析
经营活动净收益/利润总额(%)65.689124.34872.55789.42659.104
价值变动净收益/利润总额(%)34.2822.336-0.952-6.79024.078
营业外收支净额/利润总额(%)-0.318-7.5740.6320.7040.539

偿债能力分析
流动比率 (X)0.4290.2940.3250.4800.708
速动比率 (X)0.2090.1470.1580.3730.542
资产负债率 (%)77.51880.02880.15376.10164.086
带息债务/全部投入资本 (%)70.24072.36572.01468.75155.195
股东权益/带息债务 (%)36.59931.99131.93338.71772.944
股东权益/负债合计 (%)28.40724.32423.99830.42554.904
利息保障倍数 (X)6.2311.570-0.425-3.080-2.468

营运能力分析
应收账款周转天数 (天)43.86340.48172.623189.181148.743
存货周转天数 (天)256.591223.689278.077281.953391.397